Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.

Child health, developmental plasticity, and epigenetic programming. Endocr Rev (2010) 2.15

The physical phenotype of girls and women with Turner syndrome is not X-imprinted. Hum Genet (2007) 0.89

Chromosome imbalance as a driver of sex disparity in disease. J Genomics (2014) 0.88

Turner syndrome and the evolution of human sexual dimorphism. Evol Appl (2008) 0.87

Monosomy for the X chromosome. Chromosome Res (2009) 0.85

Parent of origin effects on age at colorectal cancer diagnosis. Int J Cancer (2010) 0.80

Recombinant human growth hormone in the treatment of Turner syndrome. Ther Clin Risk Manag (2008) 0.77

Effect of the parental origin of the X-chromosome on the clinical features, associated complications, the two-year-response to growth hormone (rhGH) and the biochemical profile in patients with turner syndrome. Int J Pediatr Endocrinol (2013) 0.76

High levels of education and employment among women with Turner syndrome. J Womens Health (Larchmt) (2013) 0.75

Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome. Horm Res Paediatr (2010) 0.75

No influence of parental origin of intact X chromosome and/or Y chromosome sequences on three-year height response to growth hormone therapy in Turner syndrome. Ann Pediatr Endocrinol Metab (2014) 0.75

Fingers as a marker of prenatal androgen exposure. Endocrinology (2009) 2.44

Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome. Hum Mutat (2014) 2.17

Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.92

Growth hormone plus childhood low-dose estrogen in Turner's syndrome. N Engl J Med (2011) 1.82

Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care (2002) 1.76

Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet (2006) 1.67

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol (2002) 1.65

The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr (2005) 1.58

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology (2003) 1.39

Editorial: The postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. J Clin Endocrinol Metab (2002) 1.17

Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab (2006) 1.16

Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab (2007) 1.12

Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab (2008) 1.11

Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr (2004) 1.07

Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J Clin Endocrinol Metab (2004) 1.00

Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Horm Res Paediatr (2016) 0.97

Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma. J Clin Endocrinol Metab (2014) 0.91

GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab (2013) 0.88

Massive ischemic intestinal necrosis at the onset of diabetes mellitus with ketoacidosis in a three-year-old girl. J Pediatr Surg (2003) 0.88

Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age. J Clin Endocrinol Metab (2006) 0.87

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. Int J Pediatr Endocrinol (2011) 0.86

Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol (2014) 0.86

Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment. Horm Res Paediatr (2015) 0.84

Bioinactive ACTH causing glucocorticoid deficiency. J Clin Endocrinol Metab (2013) 0.84

Meier-Gorlin syndrome: growth and secondary sexual development of a microcephalic primordial dwarfism disorder. Am J Med Genet A (2012) 0.84

Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. J Clin Endocrinol Metab (2003) 0.83

Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. J Sex Med (2005) 0.82

Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life. Pediatrics (2004) 0.81

A search for variables predicting cortisol response to low-dose corticotropin stimulation following supraphysiological doses of glucocorticoids. J Pediatr (2013) 0.81

Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency. Eur J Endocrinol (2013) 0.81

Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res (2009) 0.80

Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational study. Horm Res Paediatr (2013) 0.80

Normal minipuberty of infancy in boys with Prader-Willi syndrome. J Pediatr (2006) 0.79

Determinant factors of gender identity: a commentary. J Pediatr Urol (2012) 0.77

Abnormal motor cortex excitability is associated with reduced cortical thickness in X monosomy. Hum Brain Mapp (2011) 0.76

Response to: does IARS2 deficiency cause an intrinsic disorder of bone development (skeletal dysplasia) or are the reported skeletal changes secondary to growth hormone deficiency and neuromuscular involvement? Hum Mutat (2015) 0.75

Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial. Horm Res Paediatr (2016) 0.75

Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome. Horm Res Paediatr (2010) 0.75

Empathy, autistic traits, and motor resonance in adults with Turner syndrome. Soc Neurosci (2014) 0.75